Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
69.71
-0.19 (-0.27%)
Nov 4, 2024, 4:00 PM EST - Market closed

Belite Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
--31.63-12.65-9.67-5.75
Depreciation & Amortization
-0.40.20.030.02
Loss (Gain) From Sale of Assets
----0.01-
Stock-Based Compensation
-3.821.481.531.36
Change in Accounts Receivable
--0.02-0.03-0
Change in Accounts Payable
---0.040.05-0.02
Change in Other Net Operating Assets
--2.41-0.420.6-0.05
Operating Cash Flow
--29.84-11.46-7.47-4.44
Capital Expenditures
--0.06-0.39-0.07-0.02
Sale of Property, Plant & Equipment
---0.02-
Investing Cash Flow
--0.06-0.39-0.06-0.02
Short-Term Debt Issued
----0.13
Total Debt Issued
----0.13
Short-Term Debt Repaid
-----2.45
Total Debt Repaid
-----2.45
Net Debt Issued (Repaid)
-----2.32
Issuance of Common Stock
-77.1937.990.230.59
Other Financing Activities
--1.23-1.03-0.82-
Financing Cash Flow
-75.9636.96-0.5828.06
Foreign Exchange Rate Adjustments
-0.01-0.37-0.160
Net Cash Flow
-46.0724.75-8.2723.6
Free Cash Flow
--29.9-11.85-7.55-4.46
Free Cash Flow Per Share
--1.12-0.59-0.79-0.51
Cash Interest Paid
--0.02-0.02
Levered Free Cash Flow
--15.3-7.1-4.01-
Unlevered Free Cash Flow
--15.28-7.09-4.01-
Change in Net Working Capital
55.86-0.350.36-0.63-
Source: S&P Capital IQ. Standard template. Financial Sources.